Your browser is no longer supported. Please, upgrade your browser.
Settings
PODD Insulet Corporation daily Stock Chart
PODD [NASD]
Insulet Corporation
Index- P/E- EPS (ttm)-0.23 Insider Own0.30% Shs Outstand60.14M Perf Week-1.33%
Market Cap4.79B Forward P/E205.36 EPS next Y0.39 Insider Trans-7.99% Shs Float58.48M Perf Month-1.33%
Income-13.20M PEG- EPS next Q0.07 Inst Own98.50% Short Float10.89% Perf Quarter-25.41%
Sales529.40M P/S9.05 EPS this Y3.80% Inst Trans2.78% Short Ratio10.61 Perf Half Y-18.18%
Book/sh3.35 P/B23.79 EPS next Y- ROA-1.60% Target Price105.50 Perf Year13.71%
Cash/sh4.82 P/C16.53 EPS next 5Y25.00% ROE-7.60% 52W Range67.43 - 108.90 Perf YTD15.48%
Dividend- P/FCF- EPS past 5Y15.80% ROI-1.10% 52W High-26.84% Beta1.69
Dividend %- Quick Ratio4.00 Sales past 5Y17.00% Gross Margin64.10% 52W Low18.17% ATR3.79
Employees857 Current Ratio4.60 Sales Q/Q24.10% Oper. Margin1.90% RSI (14)42.44 Volatility3.84% 4.71%
OptionableYes Debt/Eq0.00 EPS Q/Q170.80% Profit Margin-2.50% Rel Volume0.90 Prev Close81.11
ShortableYes LT Debt/Eq2.95 EarningsNov 01 AMC Payout- Avg Volume599.86K Price79.68
Recom1.90 SMA20-2.12% SMA50-7.03% SMA200-10.80% Volume538,643 Change-1.76%
Apr-20-18Initiated Berenberg Buy $100
Feb-22-18Reiterated Barclays Overweight $85 → $90
Jan-08-18Upgrade Raymond James Mkt Perform → Outperform
Nov-03-17Upgrade Canaccord Genuity Hold → Buy $50 → $65
Sep-15-17Initiated Barclays Overweight $65
Jul-17-17Downgrade BTIG Research Buy → Neutral
May-25-17Resumed William Blair Outperform
May-22-17Resumed Piper Jaffray Overweight
Feb-28-17Reiterated Wedbush Outperform $48 → $50
Jan-06-17Upgrade Robert W. Baird Neutral → Outperform $39 → $47
Aug-04-16Reiterated Wedbush Outperform $44 → $48
Feb-26-16Upgrade The Benchmark Company Hold → Buy $30 → $40
Nov-06-15Reiterated Northland Capital Outperform $35 → $40
Nov-02-15Initiated Morgan Stanley Equal-Weight
Jul-08-15Initiated Robert W. Baird Neutral $34
May-04-15Upgrade Northland Capital Market Perform → Outperform $28 → $32
May-01-15Reiterated The Benchmark Company Buy $39 → $30
May-01-15Reiterated Oppenheimer Perform $33 → $31
Apr-15-15Reiterated Wedbush Outperform $34 → $38
Feb-27-15Downgrade Oppenheimer Outperform → Perform $39 → $33
Dec-14-18 12:43AM  Here is What Hedge Funds Think About Insulet Corporation (PODD) Insider Monkey
Dec-13-18 03:08PM  Facing headwinds, medtech sector won't be left to its own devices American City Business Journals
Dec-10-18 09:01AM  Insulet Gains on Omnipod Reimbursement Update, Rivalry Stiff Zacks
Dec-01-18 05:48PM  Insulet: Sugar or Spice? GuruFocus.com
Nov-30-18 07:00AM  Is It Time to Buy These Beaten-Up Bargains in Healthcare? Motley Fool
Nov-29-18 02:08PM  Is It Time to Buy Insulet? Motley Fool
08:45AM  Consolidated Research: 2018 Summary Expectations for Insulet, Yum China, Triton International, Tetra Technologies, Motorola Solutions, and Spotify Technology SA Fundamental Analysis, Key Performance Indications GlobeNewswire
Nov-23-18 10:11AM  What's in Store for GW Pharma (GWPH) This Earnings Season? Zacks
Nov-22-18 08:28AM  Insulet's (PODD) Omnipod DASH System Now ISO 27001 Certified Zacks
Nov-21-18 01:34PM  Here's Why Tandem Diabetes Care Is Jumping 16% Today Motley Fool
Nov-20-18 04:01PM  Insulets Omnipod DASH Insulin Management System Receives ISO 27001 Certification for Information Security Business Wire
Nov-19-18 04:01PM  Insulet to Present at Upcoming Investor Conferences Business Wire -7.16%
Nov-08-18 01:37PM  Edited Transcript of PODD earnings conference call or presentation 1-Nov-18 8:30pm GMT Thomson Reuters StreetEvents
Nov-07-18 04:01PM  Insulet Collaborates with Samsung to Deliver Galaxy Smartphone-Controlled Insulin Pump Delivery System Business Wire
12:40PM  Vanguard Health Care Fund Buys 4 Stocks in 3rd Quarter GuruFocus.com
Nov-06-18 11:59AM  TUV Rheinland OpenSky helps insulin pump by Insulet achieve cybersecurity certification by DTSec GlobeNewswire
Nov-05-18 06:42PM  How Insulet Helps People With Diabetes Live Longer and Happier Lives Bloomberg -5.34%
06:00AM  Insulet Raises Awareness for National Diabetes Awareness Month Business Wire
Nov-04-18 12:50PM  Insulet Achieves Quarterly Profitability for the First Time Motley Fool
Nov-02-18 10:55AM  Insulet (PODD) Beats Earnings and Revenue Estimates in Q3 Zacks
Nov-01-18 09:51PM  Insulet Corporation (PODD) Q3 2018 Earnings Conference Call Transcript Motley Fool
05:15PM  Insulet (PODD) Q3 Earnings and Revenues Top Estimates Zacks
04:07PM  Insulet: 3Q Earnings Snapshot Associated Press
04:01PM  Insulet Reports Third Quarter 2018 Revenue of $151.1 Million, Up 24% Year-Over-Year, and Gross Margin Over 67%, Up 700 Basis Points Business Wire
Oct-29-18 01:18PM  1 Extraordinary Investor, Plus a 5-Stock Sampler Annual Check-In Motley Fool
Oct-19-18 07:35AM  Analysis: Positioning to Benefit within Penumbra, Aetna, Littelfuse, IHS Markit, Credit Acceptance, and Insulet Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Oct-04-18 11:39AM  Europe Okays Use of Insulet's (PODD) Omnipod With Fiasp Zacks
Oct-02-18 12:01AM  Omnipod® Insulin Management System Now Available for Use in Europe with Fiasp® Fast-Acting Insulin Business Wire
Sep-27-18 11:33AM  Investing in Diabetes Stocks: A Beginner's Guide Motley Fool
Sep-24-18 06:00AM  Insulet to Announce Third Quarter 2018 Financial Results on November 1, 2018 Business Wire
Sep-19-18 09:55AM  Insulet Advances on Omnipod Reimbursement Update, Runs Risks Zacks
Sep-11-18 08:25AM  The Daily Biotech Pulse: Advaxis Posts Narrower Loss, Endocyte Announces $175M Offering, Leadership Transition At Insulet Benzinga
Sep-10-18 09:52PM  Insulet names its female president as next CEO American City Business Journals
04:01PM  Insulet Announces Shacey Petrovic, President and COO, Promoted to CEO, Effective January 1, 2019; Patrick Sullivan Will Retire as Chairman and CEO at the End of 2018 Business Wire
Sep-06-18 09:00AM  3 Growth Stocks for Forward-Looking Investors Motley Fool
Aug-28-18 06:00AM  Insulet to Present at Upcoming Investor Conferences Business Wire
Aug-17-18 07:28AM  Zacks.com featured highlights include: Entercom, Insulet, ESCO and Tristate Zacks
Aug-16-18 09:30AM  4 Top Stocks With the Power of Earnings Acceleration Zacks
06:00AM  Insulet to Showcase Its Omnipod DASH Insulin Management System at the American Association of Diabetes Educators Annual Conference Business Wire
Aug-15-18 05:40AM  Edited Transcript of PODD earnings conference call or presentation 2-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-07-18 08:50AM  Insulet (PODD) Q2 Loss Narrower Than Expected, Revenues Lag Zacks
Aug-03-18 09:00AM  Insulet Achieves Operating Profitability, but Pares Back 2018 Revenue Guidance Motley Fool
Aug-02-18 05:15PM  Insulet (PODD) Reports Q2 Loss, Lags Revenue Estimates Zacks
04:09PM  Insulet: 2Q Earnings Snapshot Associated Press
04:01PM  Insulet Reports Second Quarter 2018 Revenue of $124.3 Million, Up 13% Year-Over-Year, and Gross Margin of 66%, Up 710 Basis Points Business Wire
02:30PM  Insulet Corporation to Host Earnings Call ACCESSWIRE
08:42AM  Q2 Earnings Outlook For Insulet Benzinga
Jul-30-18 12:18PM  Hill-Rom (HRC) Q3 Earnings Top Estimates, Margins Expand Zacks
Jul-27-18 03:33PM  Zimmer Biomet (ZBH) Q2 Earnings Top Estimates, Margins Drop Zacks
12:25PM  GNC Holdings (GNC) Q2 Earnings Beat, Revenues Miss Mark Zacks
Jul-26-18 09:14AM  Align Technology (ALGN) Beats on Earnings and Revenues in Q2 Zacks
08:58AM  Chemed (CHE) Beats on Q2 Earnings & Revenues, View Raised Zacks
Jul-25-18 12:10PM  Thermo Fisher (TMO) Beats on Q2 Earnings, Ups '18 EPS View Zacks
10:18AM  Boston Scientific (BSX) Beats on Q2 Earnings, Margins Down Zacks
Jul-24-18 10:42AM  Quest Diagnostics (DGX) Q2 Earnings Meet, Guidance Narrowed Zacks
08:31AM  PetMed (PETS) Q1 Earnings Lag Estimates, Reorder Sales Solid Zacks
Jul-20-18 07:00AM  Todays Free Research Reports Coverage on Neovasc and Three More Healthcare Stocks ACCESSWIRE
Jul-12-18 04:01PM  Insulet Extends Partnership with Glooko in Europe to Optimise Diabetes Data Management Business Wire
Jul-11-18 04:01PM  Insulet to Announce Second Quarter 2018 Financial Results on August 2, 2018 Business Wire
Jul-09-18 06:00AM  Insulet Partners with the International Diabetes Federation Europe to Support Advocacy Activities Across the Continent Business Wire
Jul-06-18 12:59PM  Top Stocks Set to Disrupt the Diabetes Market Motley Fool
Jul-05-18 10:42AM  Insulet Omnipod Insulin Pump Finds Favor in British Columbia Zacks
Jul-03-18 11:06AM  Insulet Starts European Direct Operation, Braces Global Base Zacks
09:27AM  Insulet Banks on Omnipod's Growing Market Reach, Runs Risks Zacks
06:00AM  Omnipod® Insulin Management System Now the Preferred Insulin Pump in British Columbia, Canada Business Wire
Jul-02-18 12:30AM  Insulet Assumes Direct Operations of its Omnipod® Insulin Management System Product Line in Europe Business Wire
Jun-24-18 10:01AM  Insulet Presents Positive Clinical Trial Results for the Omnipod® Horizon Hybrid Closed-Loop System at the American Diabetes Association's 78th Scientific Sessions Business Wire
09:47AM  Insulet Corporation (NASDAQ:PODD): Time For A Financial Health Check Simply Wall St.
Jun-19-18 06:00AM  Insulet to Unveil New Omnipod® DASHTM System and Present Innovative Research at the American Diabetes Association's 78th Scientific Sessions Business Wire
Jun-13-18 03:41AM  Artificial Pancreas Lifts Tandem Diabetes Investopedia
Jun-12-18 07:10AM  Complimentary Technical Snapshots on Hologic and Three More Medical Supplies Stocks ACCESSWIRE
Jun-04-18 06:00AM  Insulets Omnipod® DASH Insulin Management System Receives FDA 510(k) Clearance Business Wire
May-31-18 12:10PM  3 Stocks That Have Doubled and Still Have Room to Grow Motley Fool
07:55AM  Factors of Influence in 2018, Key Indicators and Opportunity within Insulet, Everi, Ciner Resources LP, Aluminum Corporation of China, Okta, and MYOS RENS Technology New Research Emphasizes Economic Growth GlobeNewswire
May-29-18 04:01PM  Insulet to Present at Upcoming Investor Conference Business Wire
May-28-18 10:40AM  3 Innovative Medical Technology Companies Shaking Up the Diabetes Market Motley Fool
May-25-18 12:40PM  Five Top MedTech Stocks in Diabetes Motley Fool
May-09-18 04:11AM  Edited Transcript of PODD earnings conference call or presentation 3-May-18 8:30pm GMT Thomson Reuters StreetEvents
May-04-18 09:42AM  Insulet Delivers 21% Revenue Growth and Achieves Operating Profitability Breakeven Motley Fool
May-03-18 04:06PM  Insulet: 1Q Earnings Snapshot Associated Press
04:01PM  Insulet Reports First Quarter 2018 Revenue of $123.6 Million, Up 21% Year-Over-Year, and Gross Margin of 61.4%, Up 300 Basis Points, Exceeding Expectations Business Wire
05:00AM  Insulet Achieves Key Milestones to Support its Transition to Direct Operations in Europe on July 1, 2018 Business Wire
May-01-18 04:01PM  Insulet Establishes Two Significant Commercial Partnerships to Support its European Expansion Business Wire
Apr-10-18 11:01AM  Edited Transcript of PODD presentation 7-Mar-17 4:35pm GMT Thomson Reuters StreetEvents
Apr-05-18 07:45AM  Report: Developing Opportunities within Insulet, Karyopharm Therapeutics, Playa Hotels & Resorts N.V, Cision Ltd., Freightcar America, and COUPA SOFTWARE Future Expectations, Projections Moving into 2018 GlobeNewswire
06:00AM  Insulet to Announce First Quarter 2018 Financial Results on May 3, 2018 Business Wire
Mar-14-18 03:00AM  Insulet to Share Omnipod Clinical Data at Three Major European National Diabetes Congresses Business Wire
Mar-06-18 11:51AM  Analyst: Insulet On Track For Profitability In 2018 Benzinga
07:40AM  Report: Developing Opportunities within Public Service Enterprise Group, Nucor, Newmont Mining, Insulet, Hecla Mining, and Occidental Petroleum Future Expectations, Projections Moving into 2018 GlobeNewswire
Feb-28-18 08:00AM  Insulet Corporation to Present at Upcoming Investor Conferences Business Wire
Feb-22-18 02:31PM  Edited Transcript of PODD earnings conference call or presentation 21-Feb-18 9:30pm GMT Thomson Reuters StreetEvents
08:02AM  Insulet Pumps Out 26% Revenue Growth; Loss Narrows Motley Fool
Feb-21-18 04:15PM  Insulet reports 4Q loss Associated Press
04:01PM  Insulet Reports Fourth Quarter Revenue of $130.5 Million, Up 26%, and Gross Margin Up 210 Basis Points, Exceeding Expectations Business Wire
12:00PM  Insulet Corporation to Host Earnings Call ACCESSWIRE
10:43AM  Insulet Q4 Earnings Preview Benzinga
Feb-14-18 06:00AM  Insulet Has Strong Presence at the International ATTD Congress; Presents Positive Study Results for Its Omnipod Horizon Hybrid Closed-Loop System Business Wire
Jan-29-18 09:00AM  Insulet Corporation to Announce Fourth Quarter and Full Year 2017 Financial Results on February 21, 2018 Business Wire
Jan-15-18 06:01AM  Does Insulet Corporations (NASDAQ:PODD) Past Performance Indicate A Stronger Future? Simply Wall St.
Jan-10-18 08:05AM  See what the IHS Markit Score report has to say about Insulet Corp. Markit
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod Insulin Management System (Omnipod System), which consists of an easy-to-use continuous insulin delivery system; and Personal Diabetes Manager, a handheld wireless device. It also customizes the Omnipod System technology platform for the delivery of drugs over a specified interval of time, at an administered volume. The company sells and markets its Omnipod System through a combination of direct sales representatives and independent distributors. Insulet Corporation was founded in 2000 and is headquartered in Billerica, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Petrovic ShaceyPresident and COODec 06Option Exercise29.266,834199,96393,033Dec 10 05:48 PM
Colleran DavidSVP, Secretary and GCNov 14Option Exercise41.616,113254,36440,155Nov 15 04:24 PM
Abdel-Malek AimanEVP & Chief Technology OfficerNov 14Sale80.4160248,40725,551Nov 15 04:02 PM
Colleran DavidSVP, Secretary and GCNov 14Sale80.416,113491,54634,042Nov 15 04:24 PM
Petrovic ShaceyPresident and COONov 01Sale86.911,13498,55686,199Nov 05 04:34 PM
Abdel-Malek AimanEVP & Chief Technology OfficerOct 15Sale88.5860253,32526,153Oct 16 05:13 PM
Abdel-Malek AimanEVP & Chief Technology OfficerSep 14Sale107.9960265,01026,755Sep 18 05:18 PM
Petrovic ShaceyPresident and COOSep 04Sale104.26960100,09087,333Sep 05 06:14 PM
Spears Michael PSVP, QA and RAAug 14Sale86.085,043434,11327,304Aug 15 05:37 PM
Abdel-Malek AimanEVP & Chief Technology OfficerAug 14Sale86.6060252,13327,357Aug 15 05:26 PM
Abdel-Malek AimanEVP & Chief Technology OfficerJun 28Option Exercise31.2081125,30328,251Jun 29 04:07 PM
Spears Michael PSVP, QA and RAJun 13Option Exercise29.876,421191,79542,092Jun 14 04:45 PM
Spears Michael PSVP, QA and RAJun 13Sale100.006,421642,10035,671Jun 14 04:45 PM
Spears Michael PSVP, QA and RAJun 12Option Exercise29.871,07532,11036,746Jun 14 04:45 PM
Spears Michael PSVP, QA and RAJun 12Sale100.001,075107,50035,671Jun 14 04:45 PM
Petrovic ShaceyPresident and COOJun 01Sale94.721,067101,06688,293Jun 05 06:01 PM
Spears Michael PSVP, QA and RAMay 30Option Exercise29.878,071241,08143,742May 31 05:45 PM
Spears Michael PSVP, QA and RAMay 30Sale95.008,071766,74535,671May 31 05:45 PM
Spears Michael PSVP, QA and RAMay 24Option Exercise29.378,671254,68644,342May 29 04:02 PM
Spears Michael PSVP, QA and RAMay 24Sale90.008,671780,39035,671May 29 04:02 PM
Spears Michael PSVP, QA and RAMay 18Sale87.777,774682,30135,671May 22 04:14 PM
Abdel-Malek AimanEVP & Chief Technology OfficerMay 16Option Exercise31.202,39474,69328,027May 18 04:49 PM
Spears Michael PSVP, QA and RAMay 15Sale86.648,114702,99943,445May 16 04:53 PM
Colleran DavidSVP, Secretary and GCMay 15Sale86.244,956427,40537,139May 16 04:33 PM
Lemoine David ADirectorMay 01Sale84.931,08492,0648,398May 02 06:36 PM
Spears Michael PSVP, QA and RAMar 23Option Exercise29.265,166151,15753,327Mar 26 05:44 PM
Thomas Bradley AEVP Human ResourcesMar 16Sale85.003,500297,50066,828Mar 20 06:29 PM
Alpuche CharlesEVP & Chief Operations OfficerMar 15Sale84.657,090600,16942,973Mar 16 06:37 PM
Thomas Bradley AEVP Human ResourcesMar 14Sale83.817,250607,62370,328Mar 16 06:32 PM
Fallon John A.DirectorMar 14Sale84.109,000756,9139,558Mar 16 06:25 PM
Abdel-Malek AimanEVP & Chief Technology OfficerMar 13Option Exercise31.203,20599,99629,788Mar 15 06:43 PM
Petrovic ShaceyPresident and COOMar 06Sale76.811,319101,31290,017Mar 08 06:47 PM
Lemoine David ADirectorMar 06Sale76.8164149,2359,482Mar 08 06:33 PM
Thomas Bradley AEVP Human ResourcesMar 05Option Exercise32.516,150199,93780,228Mar 06 07:35 PM